Location History:
- Parsippany, NJ (US) (2003)
- Morris Plains, NJ (US) (2014)
Company Filing History:
Years Active: 2003-2014
Title: Innovations of Wenming Liu
Introduction
Wenming Liu is a notable inventor based in Morris Plains, NJ (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target DGAT1 activity. With a total of 3 patents, his work has the potential to impact the treatment of various conditions and disorders.
Latest Patents
One of his latest patents is for (4-{4-[5-(benzooxazol-2-ylamino)-pyridin-2-yl]-phenyl}-cyclohexyl)-acetic acid, which is useful for treating or preventing conditions associated with DGAT1 activity in animals, particularly humans. Another patent involves organic compounds of the structure A-L1-B-C-D-L2-E, which also aim to address disorders related to DGAT1 activity.
Career Highlights
Wenming Liu is currently associated with Novartis AG, a leading global healthcare company. His work at Novartis has allowed him to focus on innovative solutions in the pharmaceutical industry.
Collaborations
He has collaborated with notable colleagues such as Michael H Serrano-Wu and Young-shin Kwak, contributing to a dynamic research environment that fosters innovation.
Conclusion
Wenming Liu's contributions to the field of pharmaceuticals through his patents and collaborations highlight his role as a significant inventor. His work continues to pave the way for advancements in medical treatments.